Biodesix, Inc. (BDSX) vs Q32 Bio Inc. (QTTB)

A side-by-side comparison of Biodesix, Inc. and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BDSX vs QTTB

growth of $100 · dividends reinvested · last 6y
BDSX -88.7% (-30.4%/yr)QTTB -95.8% (-41.1%/yr)BDSX compounded faster over this window
050100150200250Start $100202120222023202420252026$11$4
BDSX QTTB

BDSX vs QTTB: by the numbers

  • •QTTB is the larger company ($243M vs $227M market cap).
  • •QTTB is profitable (62.87% net margin) while BDSX runs a net loss (-26.97%).
  • •QTTB grew revenue faster over the past five years (10.22% vs 5.99% CAGR).

Metrics side by side

Valuation

MetricBDSXQTTB
P/E ratioN/A2.92
P/S ratio2.214.51
P/B ratio24.852.29
EV / EBITDAN/A6.46

Profitability

MetricBDSXQTTB
Gross margin82.50%99.84%
Operating margin-31.37%31.45%
Net margin-26.97%62.87%
ROE-303.61%31.90%
ROIC-25.73%19.43%

Growth (annualized)

MetricBDSXQTTB
Revenue CAGR (5Y)5.99%10.22%
Total return CAGR (5Y)-28.49%-41.51%

Frequently asked

Which has grown faster, BDSX or QTTB?
Over the past five years, QTTB grew revenue faster — BDSX at a 5.99% CAGR versus QTTB at 10.22%.
Is BDSX or QTTB more profitable?
QTTB runs the higher net margin — BDSX at -26.97% versus QTTB at 62.87%.
How have BDSX and QTTB total returns compared?
Over the past 5 years, BDSX delivered -28.49% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.